ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• World Acceptance (WRLD) Tops Q1 EPS by 168c
• Noodles & Company (NDLS) Tops Q2 EPS by 26c ; Offers Guidance